Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and EfficacyLEE, Tong-Young; SJIN, Robert M. Tjintham; MOVAHEDI, Shahla et al.Clinical cancer research. 2008, Vol 14, Num 5, pp 1487-1493, issn 1078-0432, 7 p.Article

VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification : Fractures in osteoporosisPUFE, Thomas; MENTLEIN, Rolf; TSOKOS, Michael et al.Bone (New York, NY). 2004, Vol 35, Num 2, pp 543-552, issn 8756-3282, 10 p.Article

Endostatin and Physical Exercise in Young Female and Male Athletes and ControlsSPONDER, M; SEPTOL, K; LANKISCH, S et al.International journal of sports medicine. 2014, Vol 35, Num 13, pp 1138-1142, issn 0172-4622, 5 p.Article

Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumorsLI, H.-L; LI, S; GUAN, Z.-Z et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 4, pp 247-256, issn 0969-7128, 10 p.Article

Antiangiogenesis Effects of Endostatin in Retinal NeovascularizationBAI, Yu-Jing; HUANG, Lv-Zhen; ZHOU, Ai-Yi et al.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 7, pp 619-626, issn 1080-7683, 8 p.Article

The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularizationOLSSON, Anna-Karin; JOHANSSON, Irja; AKERUD, Helena et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 9012-9017, issn 0008-5472, 6 p.Article

Therapeutic efficacy of endostatin exhibits a biphasic dose-response curveCELIK, Ilhan; SÜRÜCÜ, Oguzkan; DIETZ, Carsten et al.Cancer research (Baltimore). 2005, Vol 65, Num 23, pp 11044-11050, issn 0008-5472, 7 p.Article

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. CommentaryFOLKMAN, Judah; HUBING SHI; YUJIE HUANG et al.Blood. 2007, Vol 110, Num 8, issn 0006-4971, 2786-2787, 2899-2906 [10 p.]Article

Therapy of hematogenous melanoma brain metastases with endostatinKIRSCH, Matthias; WEIGEL, Patrick; PINZER, Thomas et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1259-1267, issn 1078-0432, 9 p.Article

Effect of methanol feeding strategies on production and yield of recombinant mouse endostatin from Pichia pastorisTRINH, L. B; PHUE, J. N; SHILOACH, Joseph et al.Biotechnology and bioengineering. 2003, Vol 82, Num 4, pp 438-444, issn 0006-3592, 7 p.Article

The antiangiogenic and therapeutic implications of endostatinREN, B; HÖTI, N; RABASSEDA, X et al.Methods and findings in experimental and clinical pharmacology. 2003, Vol 25, Num 3, pp 215-224, issn 0379-0355, 10 p.Article

Effect of CDT6 on factors of angiogenic balance in tumour cell linesBOUÏS, Diane R. M. H; DAM, Wendy A; MEIJER, Coby et al.Anticancer research. 2007, Vol 27, Num 4B, pp 2325-2329, issn 0250-7005, 5 p.Article

Antiangiogenic treatment with endostatin inhibits progression of AML in vivoSCHUCH, G; OLIVEIRA-FERRER, L; LOGES, S et al.Leukemia. 2005, Vol 19, Num 8, pp 1312-1317, issn 0887-6924, 6 p.Article

Serum endostatin levels in patients with epithelial ovarian cancerHATA, Kohkichi; DIPOK KUMAR DHAR; KANASAKI, Haruhiko et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1907-1912, issn 0250-7005, 6 p.Article

Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitroAL AHMAD, Abraham; LEE, Boyeon; STACK, Jonathan et al.Brain research. 2010, Vol 1360, pp 28-39, issn 0006-8993, 12 p.Article

Molecular mechanisms regulating the angiogenic phenotype in tumors : Clinical impact in the futureAUBRY, Karine; BARRIERE, Guilaine; CHABLE-RABINOVITCH, Helene et al.Anticancer research. 2007, Vol 27, Num 5A, pp 3111-3119, issn 0250-7005, 9 p.Article

Autoantibodies to endostatin in patients with breast cancer : correlation to endostatin levels and clinical outcomeBACHELOT, T; RATEL, D; MENETRIER-CAUX, C et al.British journal of cancer. 2006, Vol 94, Num 7, pp 1066-1070, issn 0007-0920, 5 p.Article

Endostatin expression in pancreatic tissue is modulated by elastaseBRAMMER, R. D; BRAMHALL, S. R; EGGO, M. C et al.British journal of cancer. 2005, Vol 92, Num 1, pp 89-93, issn 0007-0920, 5 p.Article

Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections : a phase I and pharmacokinetic study in patients with advanced cancerHANSMA, A. H. G; BROXTERMAN, H. J; VAN DER HORST, I et al.Annals of oncology. 2005, Vol 16, Num 10, pp 1695-1701, issn 0923-7534, 7 p.Article

Expression pattern and circulating levels of endostatin in patients with pancreas cancerOHLUND, Daniel; ARDNOR, Bjarne; OMAN, Mikael et al.International journal of cancer. 2008, Vol 122, Num 12, pp 2805-2810, issn 0020-7136, 6 p.Article

TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samplesPIKNER, R; LUDVIKOVA, M; RYSKA, A et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1517-1521, issn 0250-7005, 5 p.Article

Endostatin inhibits the growth of endometriotic lesions but does not affect fertilityBECKER, Christian M; SAMPSON, David A; RUPNICK, Maria A et al.Fertility and sterility. 2005, Vol 84, pp 1144-1155, issn 0015-0282, 12 p., SUP2Article

Pleural mesothelial cell (PMC) defense mechanisms against malignancyNASREEN, Najmunnisa; MOHAMMED, Kamal A; SANDERS, Kerry et al.Oncology research. 2003, Vol 14, Num 3, pp 155-161, issn 0965-0407, 7 p.Article

Generation of endostatin by matrix metalloproteinase and cathepsin from human limbocorneal epithelial cells cultivated on amniotic membraneMA, David Hui-Kang; YAO, Jeng-Yuan; KUO, Ming-Tse et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 2, pp 644-651, issn 0146-0404, 8 p.Article

A 27-amino-acid synthetic peptide corresponding to the NH₂-terminal zinc-binding domain of endostatin is responsible for its antitumor activityTJIN THAM SJIN, Robert M; SATCHI-FAINARO, Ronit; BIRSNER, Amy E et al.Cancer research (Baltimore). 2005, Vol 65, Num 9, pp 3656-3663, issn 0008-5472, 8 p.Article